Catheter Precision Inc (VTAK)
0.565
+0.04
(+7.62%)
USD |
NYAM |
May 03, 16:00
0.565
0.00 (0.00%)
After-Hours: 20:00
Catheter Precision Net Income (Quarterly): -0.669M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.669M |
September 30, 2023 | -1.927M |
June 30, 2023 | -1.576M |
March 31, 2023 | -66.40M |
December 31, 2022 | -8.159M |
September 30, 2022 | -4.763M |
June 30, 2022 | -8.448M |
March 31, 2022 | -5.495M |
December 31, 2021 | -8.287M |
September 30, 2021 | -4.298M |
June 30, 2021 | -5.249M |
March 31, 2021 | -7.236M |
December 31, 2020 | -10.44M |
September 30, 2020 | -7.779M |
Date | Value |
---|---|
June 30, 2020 | -10.12M |
March 31, 2020 | -7.701M |
December 31, 2019 | -9.743M |
September 30, 2019 | -17.42M |
June 30, 2019 | -15.12M |
March 31, 2019 | -14.67M |
December 31, 2018 | -14.94M |
September 30, 2018 | -4.807M |
June 30, 2018 | -8.395M |
March 31, 2018 | -2.693M |
December 31, 2017 | -3.096M |
September 30, 2017 | -1.72M |
June 30, 2017 | -11.28M |
March 31, 2017 | -1.662M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-66.40M
Minimum
Mar 2023
-0.669M
Maximum
Dec 2023
-10.57M
Average
-7.779M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
Perspective Therapeutics Inc | -24.68M |
Retractable Technologies Inc | -0.0729M |
InfuSystems Holdings Inc | 0.072M |
Xtant Medical Holdings Inc | -4.303M |
Asensus Surgical Inc | -17.24M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.128M |
Total Expenses (Quarterly) | 2.725M |
EPS Diluted (Quarterly) | 1.21 |
Enterprise Value | 0.595M |
Gross Profit Margin (Quarterly) | 94.53% |
Profit Margin (Quarterly) | -522.7% |
Earnings Yield | -4.25K% |
Normalized Earnings Yield | -448.70 |